ArticleJournal for immunotherapy of cancer2022

Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions.

Ziena Abdulrahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.